Cecilia Pessoa Gingerich

The application was based on data from the EXPAND phase 3 trial of siponimod in adults with secondary progressive multiple sclerosis.

Investigators analyzed data from PrEP-eligible patients at the New York City Health + Hospital/Bellevue which showed that women and minority patients were less likely to be prescribed PrEP for HIV prevention.

Race and sex can play a role in the annual BMI gain for patients with HIV who are receiving certain antiretroviral therapy combinations.

An intervention of scheduling an appointment and contacting the patient successfully increased re-engagement among patients with HIV who had not had a primary care visit in the previous 6 months.

An interview-based qualitative study found that minority residents face extra burdens during training due to racial/ethnic bias and microaggressions.

Galcanezumab will be available as a monthly 120 mg injection in pen and syringe forms for the prevention of migraine in adults.

The FDA has approved a 0.15mg dosage of Symjepi, an epinephrine injection, for the emergency treatment of serious allergic reactions in children.

The FDA recognized the potential of proCase, which is being developed to treat blood clots and does not increase the risk of bleeding.

The Eluvia stent system was approved based on data from the IMPERIAL non-inferiority trial, which compared Eluvia to Zilver PTX.

The capsules of icosapent ethyl, which is derived from fish, showed a 25% relative risk reduction compared to placebo.

Lucia Novak discusses the importance of testing for cardiovascular outcomes of diabetes treatments and compares the cardiovascular effects of several diabetes drugs.

Lucia Novak, a diabetes care specialist, discusses some of the gaps that remain in diabetes management and what providers can do to help bridge those.

A placebo-controlled study of daily low-dose aspirin found that treatment did not prolong healthy living in older adults. In fact, aspirin use was associated with increased risk of major hemorrhage.

A new statement from the US Preventive Services Task Force emphasizes the need for behavior-based interventions to help adults with obesity lose weight and maintain lower weight.

The device is a balloon catheter designed to treat rare, but life-threatening perforations in the coronary artery, which can occur during Percutaneous Coronary Intervention procedures.

The supplemental BLA seeks FDA approval for alirocumab (Praulent) as a treatment to reduce overall risk of major adverse cardiovascular events.

A study of primary care patients found that of patients screened for alcohol use, just 2.4% were also screened for depression. Men and racial/ethnic minorities were less likely to be screened for depression.

High Impact Chronic Pain encompasses individuals with chronic pain who also have a disability. Data collected in this study will help improve care for patients with HICP and guide future research.

Deaths due to drug overdoses and suicides have contributed to decreasing US life expectancy, but other factors indicate that there is a deeper root cause driving these trends.

Tiglutik, a thickened liquid suspension of riluzole, was developed to ease administration for patients with amyotrophic lateral sclerosis (ALS) who have difficulty swallowing tablets.

The New Drug Application is based on data from 5 phase 3 studies of the efficacy and safety of esketamine nasal spray for treatment-resistant depression.

A small study found that ketamine decreased symptoms of depression—investigators studied its effects in combination with the opioid-blocker naltrexone compared to a placebo.

As more physicians are caring for transgender patients, many are finding they are unprepared and they lack the training, skills, and resources to do so, according to the authors of a recent review article.

Altreno is a lotion containing .05% tretinoin, a retinoid that reduces inflammation and lesions associated with acne vulgaris.

Oxervate eye drops, which contain cenegermin, are the first approved treatment for a rare condition that affects fewer than 5 in 10,000 individuals.

Results from a 12-month extension study show that elagolix taken with hormone therapy reduced menstrual blood loss in 87.9% of women with uterine fibroids.

Stiripentol (Diacomit) has been approved for treatment in patients 2 years of age and older with Dravet syndrome, a rare form of epilepsy.

The Luminelle DTx Hysteroscopy System can be used in-office by physicians to visually assess suspicious tissue in the uterus and allow for a visually-aided biopsy.

Compared to those with LDL cholesterol levels 160 mg/dL had a 70-90% increased risk.

Troy Trygstad spoke with MD Magazine ® about the potential for a pandemic flu and emphasized that there’s no “crystal ball” to help predict this.